Do you have questions about CBD? Here’s a roundup of some of the professional opinions of medical experts and health organizations.
CBD, short for cannabidiol, is a naturally occurring compound that comes from the marijuana plant, or its close relative hemp. All CBD products sold at Simply CBD are derived from hemp and are independently verified to be 100% free of THC.
A growing body of research shows CBD’s anti-inflammatory properties, positive effects on brain chemistry, and a host of other potential health and wellness benefits. Researchers are looking at how CBD can affect medical conditions including depression and neurological diseases, relieve chronic and other forms of pain, and help minimize withdrawal symptoms associated with smoking cessation and substance abuse, including opiates.
While more research is needed to explore the extent of CBD’s full potential, its worldwide acceptance is growing. Prestigious organizations and acclaimed institutions across the globe are getting on board as more studies are being conducted and endorsed, and potential health and wellness benefits are being acknowledged.
Here’s a sample of what the experts had to say about CBD, its uses, effects, and benefits.
“In humans, CBD exhibits no effects indicative of any abuse or dependence potential. CBD has been demonstrated as an effective treatment of epilepsy in several clinical trials, with one pure CBD product (Epidiolex®) currently in Phase III trials. There is also preliminary evidence that CBD may be a useful treatment for a number of other medical conditions.”
World Health Organization (WHO)
“There is a growing body of research that suggests CBD has anti-anxiety and anti-psychotic properties.”
Dr. Kevin Hill, director of the Division of Addiction Psychiatry at Beth Israel Deaconess Medical Center
“Cannabis and cannabinoids may have benefits in treating the symptoms of cancer or the side effects of cancer therapies. … Cannabis has been shown to kill cancer cells in the laboratory.”
“In recent years, a number of studies have shown the benefit of specific plant-based CBD product in treating specific groups of people with epilepsy who have not responded to traditional therapies.”
“Published cannabinoid research on pubmed.gov presents compelling potential outcomes. When a regular and therapeutic dose of cannabidiol is administered, systematic reductions of inflammation occur. Beyond chronic pain and arthritis from sports injuries, inflammation is widely accepted as a primary precursor of major disorder groups, from diabetes, epilepsy, and multiple sclerosis to brain, breast and prostate cancer.”
Dr. Sunil Pai, M.D., founder of the Sanjevani Integrative Medicine Health Center
“These data show for the first time that the phytocannabinoids CBD, CBDV, and THCV can regulate skeletal muscle cell differentiation. In particular the phytocannabinoids CBD and CBDV produced a statistically significant increase in myoblast differentiation (in contrast to the other cannabinoids)…”
Muscular Dystrophy Association, in a discussion of differentiation of myoblast cells, which is essential in the development and regeneration of muscle fibers
“Federal regulations impede the research necessary to evaluate and determine the therapeutic use of marijuana and related cannabinoids. … The ANA strongly supports […] establishing evidence-based standards for the use of marijuana and related cannabinoids.”
“CBD is non-intoxicating and has anti-inflammatory, analgesic, and antipsychotic properties. … It is known that cannabis strains, containing CBD levels equal or higher than THC, have positive effects on muscle spasticity and pain…”
Thorsten Rudroff and Justin M. Honce, department of health and exercise science, Colorado State University/department of radiology, University of Colorado School of Medicine
“This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies. … We’ll continue to support rigorous scientific research on the potential medical uses of marijuana-derived products and work with product developers who are interested in bringing patients safe and effective, high-quality products.”
Scott Gottlieb, FDA commissioner, in a June 2018 statement on FDA’s approval of Epidiolex to treat two rare forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome.
Still have questions about the safety and efficacy of CBD? At Simply CBD, we’re actively following the science to keep our customers informed, and we’re more than happy to show you how to use any of our products and discuss the dosage that might work best for you. Stop by our shop in the New Orleans’ Marigny to learn more about CBD and to check out our huge selection of hemp-derived CBD products.